saponarin and Sleep-Wake-Disorders

Treatment of sleep disorders promotes the long-term use of commercially available sleep inducers that have several adverse effects, including addiction, systemic fatigue, weakness, loss of concentration, headache, and digestive problems. Therefore, we aimed to limit these adverse effects by investigating a natural product, the extract of the Hibiscus syriacus Linnaeus flower (HSF), as an alternative treatment. In the electric footshock model, we measured anxiety and assessed the degree of sleep improvement after administering HSF extract. In the restraint model, we studied the sleep rate using PiezoSleep, a noninvasive assessment system. In the pentobarbital model, we measured sleep improvement and changes in sleep-related factors. Our first model confirmed the desirable effects of HSF extract and its active constituent, saponarin, on anxiolysis and Wake times. HSF extract also increased REM sleep time. Furthermore, HSF extract and saponarin increased the expression of cortical GABA

Topics: Animals; Apigenin; Cerebral Cortex; Corticosterone; Disease Models, Animal; Electroencephalography; Glucosides; Hibiscus; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Pentobarbital; Plant Extracts; Preoptic Area; Proto-Oncogene Proteins c-fos; Rats, Sprague-Dawley; Receptors, GABA-A; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Stress, Psychological